Business Description
Vimab Group AB
ISIN : SE0007439633
Compare
Compare
Traded in other countries / regions
VIMAB.SwedenNM4.Germany IPO Date
2015-10-02Description
Vimab Group AB is a Nordic company helping companies with transformation and improvement initiatives. It offers services including Interim management, Executive search.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.1 | |||||
Equity-to-Asset | 0.2 | |||||
Debt-to-Equity | 2.28 | |||||
Debt-to-EBITDA | 4.84 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 1.59 | |||||
Beneish M-Score | -1.86 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -38.1 | |||||
3-Year FCF Growth Rate | -92.3 | |||||
3-Year Book Growth Rate | -50.2 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 15.32 | |||||
9-Day RSI | 26.38 | |||||
14-Day RSI | 32.44 | |||||
6-1 Month Momentum % | -11.54 | |||||
12-1 Month Momentum % | 0.86 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1 | |||||
Quick Ratio | 0.67 | |||||
Cash Ratio | 0.1 | |||||
Days Inventory | 128.74 | |||||
Days Sales Outstanding | 49.56 | |||||
Days Payable | 86.13 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -101.8 | |||||
Shareholder Yield % | -28.93 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 67.94 | |||||
Operating Margin % | -1.4 | |||||
Net Margin % | -3.77 | |||||
FCF Margin % | -0.24 | |||||
ROE % | -20.7 | |||||
ROA % | -4.85 | |||||
ROIC % | -2.19 | |||||
ROC (Joel Greenblatt) % | -5.26 | |||||
ROCE % | -1.88 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 5.39 | |||||
Price-to-Owner-Earnings | 36.45 | |||||
PS Ratio | 0.43 | |||||
PB Ratio | 2.72 | |||||
EV-to-EBIT | -86.76 | |||||
EV-to-Forward-EBIT | 10.68 | |||||
EV-to-EBITDA | 8.75 | |||||
EV-to-Revenue | 0.68 | |||||
EV-to-Forward-Revenue | 0.73 | |||||
EV-to-FCF | -283.09 | |||||
Price-to-Projected-FCF | 0.79 | |||||
Earnings Yield (Greenblatt) % | -1.15 | |||||
FCF Yield % | -0.5 | |||||
Forward Rate of Return (Yacktman) % | 92.12 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vimab Group AB Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | 369.165 | ||
EPS (TTM) (kr) | -0.683 | ||
Beta | 1.08 | ||
Volatility % | 34.73 | ||
14-Day RSI | 32.44 | ||
14-Day ATR (kr) | 0.310126 | ||
20-Day SMA (kr) | 7.845 | ||
12-1 Month Momentum % | 0.86 | ||
52-Week Range (kr) | 6.6 - 11.94 | ||
Shares Outstanding (Mil) | 23.91 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Vimab Group AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Vimab Group AB Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
Vimab Group AB Frequently Asked Questions
What is Vimab Group AB(OSTO:VIMAB)'s stock price today?
The current price of OSTO:VIMAB is kr7.40. The 52 week high of OSTO:VIMAB is kr11.94 and 52 week low is kr6.60.
When is next earnings date of Vimab Group AB(OSTO:VIMAB)?
The next earnings date of Vimab Group AB(OSTO:VIMAB) is 2024-11-05.
Does Vimab Group AB(OSTO:VIMAB) pay dividends? If so, how much?
Vimab Group AB(OSTO:VIMAB) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |